| Product Code: ETC8964409 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Apixaban Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Apixaban Market - Industry Life Cycle |
3.4 Romania Apixaban Market - Porter's Five Forces |
3.5 Romania Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 Romania Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 Romania Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Romania Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Romania |
4.2.2 Growing awareness about the benefits of apixaban over traditional anticoagulants |
4.2.3 Rising geriatric population in Romania requiring anticoagulant therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and sale of apixaban in Romania |
4.3.2 Competition from other anticoagulant drugs in the market |
5 Romania Apixaban Market Trends |
6 Romania Apixaban Market, By Types |
6.1 Romania Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 Romania Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 Romania Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 Romania Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 Romania Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 Romania Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Romania Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Romania Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 Romania Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Romania Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Romania Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Romania Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Romania Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 Romania Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Romania Apixaban Market Import-Export Trade Statistics |
7.1 Romania Apixaban Market Export to Major Countries |
7.2 Romania Apixaban Market Imports from Major Countries |
8 Romania Apixaban Market Key Performance Indicators |
8.1 Number of prescriptions for apixaban in Romania |
8.2 Patient adherence and persistence rates with apixaban therapy |
8.3 Number of healthcare providers trained on prescribing apixaban |
8.4 Frequency of adverse events reported related to apixaban therapy |
8.5 Number of clinical studies and trials conducted on apixaban in Romania |
9 Romania Apixaban Market - Opportunity Assessment |
9.1 Romania Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 Romania Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 Romania Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Romania Apixaban Market - Competitive Landscape |
10.1 Romania Apixaban Market Revenue Share, By Companies, 2024 |
10.2 Romania Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here